Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer associated with
advanced age and immunosuppression. Over the past decade, an association has been …

Skin cancer is a global threat to the healthcare system and is estimated to incline
tremendously in the next 20 years, if not diagnosed at an early stage. Even though it is …

PURPOSE Merkel cell carcinoma (MCC) is an aggressive skin cancer often caused by the
Merkel cell polyomavirus. Clinical trials of programmed cell death-1 pathway inhibitors for …

Abstract Purpose of Review The therapeutic landscape for non-melanoma skin cancer
(NMSC) has recently expanded with the development of effective and targeted …

As the incidence of cutaneous malignancies continues to rise and their treatment with
immunotherapy expands, dermatologists and their patients are more likely to encounter …

Background: Non-melanoma skin cancer (NMSC) stands as an umbrella term for common
cutaneous malignancies, including basal cell carcinoma (BCC) and cutaneous squamous …

Approximately one‐third of Merkel cell carcinoma (MCC) patients eventually develop distant
metastatic disease. Little is known about whether the location of the primary lesion is …

Simple Summary In this review, we discuss a rare skin cancer that occurs mostly in elderly
people called “Merkel cell carcinoma”(MCC). The incidence is increasing due to ageing of …

Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer
whose incidence has almost doubled in recent decades. Risk factors for MCC include age> …

Recent advances in the field of immuno-oncology have translated into breakthrough
treatments for many solid and hematological malignancies. The prior study of …